Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Why avoid the hippocampus? A comprehensive review.

Gondi V, Tomé WA, Mehta MP.

Radiother Oncol. 2010 Dec;97(3):370-6. doi: 10.1016/j.radonc.2010.09.013. Epub 2010 Oct 20. Review.

2.

Consequences of ionizing radiation-induced damage in human neural stem cells.

Acharya MM, Lan ML, Kan VH, Patel NH, Giedzinski E, Tseng BP, Limoli CL.

Free Radic Biol Med. 2010 Dec 15;49(12):1846-55. doi: 10.1016/j.freeradbiomed.2010.08.021. Epub 2010 Sep 6.

PMID:
20826207
3.

Cognitive Sparing during the Administration of Whole Brain Radiotherapy and Prophylactic Cranial Irradiation: Current Concepts and Approaches.

Marsh JC, Gielda BT, Herskovic AM, Abrams RA.

J Oncol. 2010;2010:198208. doi: 10.1155/2010/198208. Epub 2010 Jun 27.

4.

Hippocampal-sparing whole-brain radiotherapy: a "how-to" technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy.

Gondi V, Tolakanahalli R, Mehta MP, Tewatia D, Rowley H, Kuo JS, Khuntia D, Tomé WA.

Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1244-52. doi: 10.1016/j.ijrobp.2010.01.039.

5.

Sparing of the neural stem cell compartment during whole-brain radiation therapy: a dosimetric study using helical tomotherapy.

Marsh JC, Godbole RH, Herskovic AM, Gielda BT, Turian JV.

Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):946-54. doi: 10.1016/j.ijrobp.2009.12.012. Epub 2010 May 14.

PMID:
20472348
6.

Glycogen synthase kinases-3beta controls differentiation of malignant glioma cells.

Li Y, Lu H, Huang Y, Xiao R, Cai X, He S, Yan G.

Int J Cancer. 2010 Sep 1;127(6):1271-82. doi: 10.1002/ijc.25020.

7.

EGFRvIII and DNA double-strand break repair: a molecular mechanism for radioresistance in glioblastoma.

Mukherjee B, McEllin B, Camacho CV, Tomimatsu N, Sirasanagandala S, Nannepaga S, Hatanpaa KJ, Mickey B, Madden C, Maher E, Boothman DA, Furnari F, Cavenee WK, Bachoo RM, Burma S.

Cancer Res. 2009 May 15;69(10):4252-9. doi: 10.1158/0008-5472.CAN-08-4853. Epub 2009 May 12.

8.

Lithium-mediated protection of hippocampal cells involves enhancement of DNA-PK-dependent repair in mice.

Yang ES, Wang H, Jiang G, Nowsheen S, Fu A, Hallahan DE, Xia F.

J Clin Invest. 2009 May;119(5):1124-35.

9.

Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-kappaB, and glucose regulation.

Kotliarova S, Pastorino S, Kovell LC, Kotliarov Y, Song H, Zhang W, Bailey R, Maric D, Zenklusen JC, Lee J, Fine HA.

Cancer Res. 2008 Aug 15;68(16):6643-51. doi: 10.1158/0008-5472.CAN-08-0850.

10.

Inhibition of glycogen synthase kinase 3 beta attenuates neurocognitive dysfunction resulting from cranial irradiation.

Thotala DK, Hallahan DE, Yazlovitskaya EM.

Cancer Res. 2008 Jul 15;68(14):5859-68. doi: 10.1158/0008-5472.CAN-07-6327. Erratum in: Cancer Res. 2008 Oct 1;68(19):8189.

11.

Protective effect of N-acetylcysteine against radiation induced DNA damage and hepatic toxicity in rats.

Mansour HH, Hafez HF, Fahmy NM, Hanafi N.

Biochem Pharmacol. 2008 Feb 1;75(3):773-80. Epub 2007 Sep 25.

PMID:
18028880
13.

Distribution of brain metastases in relation to the hippocampus: implications for neurocognitive functional preservation.

Ghia A, Tomé WA, Thomas S, Cannon G, Khuntia D, Kuo JS, Mehta MP.

Int J Radiat Oncol Biol Phys. 2007 Jul 15;68(4):971-7. Epub 2007 Apr 18.

PMID:
17446005
14.

The comet assay: a method to measure DNA damage in individual cells.

Olive PL, Banáth JP.

Nat Protoc. 2006;1(1):23-9.

PMID:
17406208
15.

Lithium treatment prevents neurocognitive deficit resulting from cranial irradiation.

Yazlovitskaya EM, Edwards E, Thotala D, Fu A, Osusky KL, Whetsell WO Jr, Boone B, Shinohara ET, Hallahan DE.

Cancer Res. 2006 Dec 1;66(23):11179-86.

16.

Changes in attentional performance of children and young adults with localized primary brain tumors after conformal radiation therapy.

Kiehna EN, Mulhern RK, Li C, Xiong X, Merchant TE.

J Clin Oncol. 2006 Nov 20;24(33):5283-90.

PMID:
17114662
17.

Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the Childhood Cancer Survivor Study.

Bowers DC, Liu Y, Leisenring W, McNeil E, Stovall M, Gurney JG, Robison LL, Packer RJ, Oeffinger KC.

J Clin Oncol. 2006 Nov 20;24(33):5277-82. Epub 2006 Nov 6.

PMID:
17088567
18.

Highly potent and specific GSK-3beta inhibitors that block tau phosphorylation and decrease alpha-synuclein protein expression in a cellular model of Parkinson's disease.

Kozikowski AP, Gaisina IN, Petukhov PA, Sridhar J, King LT, Blond SY, Duka T, Rusnak M, Sidhu A.

ChemMedChem. 2006 Feb;1(2):256-66.

PMID:
16892358
19.

Plasmid-based assays for DNA end-joining in vitro.

Iliakis G, Rosidi B, Wang M, Wang H.

Methods Mol Biol. 2006;314:123-31.

PMID:
16673879
20.

Checkpoint kinase 2-mediated phosphorylation of BRCA1 regulates the fidelity of nonhomologous end-joining.

Zhuang J, Zhang J, Willers H, Wang H, Chung JH, van Gent DC, Hallahan DE, Powell SN, Xia F.

Cancer Res. 2006 Feb 1;66(3):1401-8.

Supplemental Content

Support Center